GlaucomaNCT07163676
Is There a Response of Glaucoma to Baduanjin Exercise in Elders?
A study testing Baduanjin exercise in people with Glaucoma, run by Cairo University at 1 site in Egypt.
Trial summary
glaucoma is prevalent between elders. Baduanjin exercise is a suitable exercise for elders. elders with glaucoma will divided to group I or group II. each/every group will contain 30 elders. group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks. Read more about this study
- Who is it for?
- Ages 65 to 75 years
- Conditions the study is for
- Glaucoma
- What is being tested?
- Baduanjin exercise
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 11 May 2025to 1 Oct 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 to 75 years
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- high-tension primary open angle glaucoma (bilateral)
- ocular hypertension in both eyes
Who cannot join
- cataract
- diabetes
- cardiac disorders
- obesity
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
ali mohamed, lecturer contact
Egypt1 site, 1 recruiting
- Recruiting
Cairo University
Giza, Dokki
ali ismail, lecturer, 02 01005154209, ali.mohamed@pt.cu.edu.eg
About this study
glaucoma is prevalent between elders. Baduanjin exercise is a suitable exercise for elders. elders with glaucoma will divided to group I or group II. each/every group will contain 30 elders. group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks. group II will act as waistlist.
Read the detailed description
Baduanjin exercise is a suitable exercise for elders. elders with glaucoma will divided to group I or group II. each/every group will contain 30 elders. group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks. group II will act as waistlist.
- Conditions
- Glaucoma
- Being tested
- Baduanjin exercise
- Medical subject headings
- Glaucoma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Baduanjin exerciseBehavioural
group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks.
| Study group | Role | What they receive |
|---|---|---|
| group number 1 | Experimental | group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks. Receives: Behavioral: Baduanjin exercise |
| group number 2 | No intervention | group II will act as waistlist. |
What is being measured
The primary outcome is the main question the study is designed to answer.
intraocular pressure
it will be assessed in both eyes
Measured: it will be measured after 8 weeks
Secondary outcomes (5)
patient health questionnaire
it is nine-item questionnaire assessing depression
Measured: it will be measured after 8 weeks
National Eye Institute Visual Function Questionnaire
it is 25-item questionnaire
Measured: it will be measured after 8 weeks
Glaucoma-related quality of life questionnaire
it is a quality of life questionnaire
Measured: it will be measured after 8 weeks
State trait anxiety inventory
it is a questionnaire about anxiety
Measured: it will be measured after 8 weeks
Stress vulnerability scale
it is a questionnaire about Stress vulnerability
Measured: it will be measured after 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Sep 2025
- Study start11 May 2025
- Primary completion1 Oct 2025 (estimated)
- Study completion1 Oct 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for GlaucomaStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ali Mohamed Ali ismail, Cairo University
- Investigators
- Ali MA Ismail, lecturer, Principal investigator, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07163676
- Sponsor's protocol ID
- IRB00014233-35
- Status last verified
- Sep 2025
- First submitted
- 2 Sep 2025
- Last updated
- 9 Sep 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Is There a Response of Glaucoma to Baduanjin Exercise in Elders?
- ClinicalTrials.gov ID
- NCT07163676
- Acronym / sponsor ID
- IRB00014233-35
- Conditions
- Glaucoma
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 11 May 2025 (actual)
- Primary completion
- 1 Oct 2025 (estimated)
- Study completion
- 1 Oct 2025 (estimated)
- First posted
- 9 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
glaucoma is prevalent between elders. Baduanjin exercise is a suitable exercise for elders. elders with glaucoma will divided to group I or group II. each/every group will contain 30 elders. group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks. group II will act as waistlist.
Detailed description
Baduanjin exercise is a suitable exercise for elders. elders with glaucoma will divided to group I or group II. each/every group will contain 30 elders. group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks. group II will act as waistlist.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| group number 1 | Experimental | Behavioral: Baduanjin exercisegroup I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks. |
| group number 2 | No intervention | –group II will act as waistlist. |
Who may qualify
- Ages
- 65 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (2 listed)
- high-tension primary open angle glaucoma (bilateral)
- ocular hypertension in both eyes
Key exclusion criteria (4 listed)
- cataract
- diabetes
- cardiac disorders
- obesity
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Baduanjin exercisegroup I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks. | Behavioural | group number 1 |
Primary outcome
intraocular pressure
Time frame: it will be measured after 8 weeks
it will be assessed in both eyes
5 secondary outcomes
patient health questionnaire
Time frame: it will be measured after 8 weeks
National Eye Institute Visual Function Questionnaire
Time frame: it will be measured after 8 weeks
Glaucoma-related quality of life questionnaire
Time frame: it will be measured after 8 weeks
State trait anxiety inventory
Time frame: it will be measured after 8 weeks
Stress vulnerability scale
Time frame: it will be measured after 8 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Sep 2025.
Related trials for Glaucoma
Recruiting
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
Glaucoma, Ocular Hypertension
Not yet recruiting
AI-Assisted vs Conventional Teleglaucoma Referral
Glaucoma
Recruiting
Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment
Retinitis Pigmentosa (RP), Rod Cone Dystrophy
Recruiting
Automated Applanation Tonometry - Updated
Glaucoma, Glaucoma, Suspect
RecruitingPhase 2
A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.
Primary Open - Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
ali mohamed, lecturer contact
Ali MA Ismail, lecturer principal investigator
Cairo University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Baduanjin exercise in people with Glaucoma, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 9 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ali MA Ismail, lecturer (01005154209, ali.mohamed@pt.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
intraocular pressure (time frame: it will be measured after 8 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2025.